Alterity Therapeutics Ltd (ASX:ATH) Stock News, Headlines & Updates
Alterity Therapeutics Ltd Stock News from GuruFocus
- 1
Jun 23, 2025
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
Marketwired • 7:00am
Alterity Therapeutics to Provide Corporate Update in Fireside Chat | ATHE Stock News
GuruFocus News • 6:45am
May 12, 2025
ATHE Showcases MSA Clinical Programs at 2025 International Conference | ATHE Stock News
GuruFocus News • 7:34am
Alterity Therapeutics (ATHE) Showcases Advancements at International MSA Congress | ATHE Stock News
GuruFocus News • 7:32am
Alterity Therapeutics Prominently Featured at the International MSA Congress
Marketwired • 7:00am
Alterity Therapeutics Prominently Featured at the International MSA Congress | ATHE Stock News
GuruFocus News • 6:45am
May 09, 2025
JPMorgan Chase & Co. Acquires Significant Stake in Alterity Therapeutics Ltd
GuruFocus News • 7:31pm
May 07, 2025
Alterity Therapeutics (ATHE) Receives FDA Fast Track Designation for MSA Treatment | ATHE Stock News
GuruFocus News • 11:30am
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
Marketwired • 8:00am
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress | ATHE Stock News
GuruFocus News • 7:30am
May 05, 2025
Alterity Therapeutics (ATHE) Gains FDA Fast Track Status for MSA Treatment | ATHE Stock News
GuruFocus News • 7:01am
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
Marketwired • 7:00am
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy | ATHE Stock News
GuruFocus News • 6:45am
Apr 30, 2025
Alterity Therapeutics (ATHE) Advances ATH434 Development Amid Strong Financial Performance | ATHE Stock News
GuruFocus News • 7:20am
Appendix 4C -- Q3 FY25 Quarterly Cash Flow Report
Marketwired • 7:00am
Appendix 4C -- Q3 FY25 Quarterly Cash Flow Report | ATHE Stock News
GuruFocus News • 6:45am
Apr 28, 2025
Alterity Therapeutics (ATHE) Reports Promising Phase 2 Trial Results for ATH434 | ATHE Stock News
GuruFocus News • 7:16am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news